1. The effects of exercise on cardiovascular disease risk factors and cardiovascular physiology in rheumatoid arthritis

   • George S. Metsios
   • R. H. Moe
   • The IMPACT-RMD Consortium

   Review 04 December 2019 Pages: 347 - 357

   

2. A positive Helicobacter pylori test is associated with low spondylarthritis incidence in a Danish historical cohort study

   • Lars E. Bartels
   • Alma B. Pedersen
   • Jens F. Dahlerup

   Cohort Studies 04 December 2019 Pages: 359 - 366

   

3. Tobacco smoking is an independent factor associated with retinal damage in systemic lupus erythematosus: a cross-sectional and retrospective study

   • Iñigo Rúa-Figueroa
   • Celia Erausquin
   • Carlos Rodríguez-Lozano

   Observational Research 27 November 2019 Pages: 367 - 374

4. Physical activity and sedentary behaviour and their associations with clinical measures in axial spondyloarthritis

   • Elaine H. Coulter
   • Marie Therese McDonald
   • Lorna Paul

   Observational Research Open access 17 December 2019 Pages: 375 - 381

5. Comparison of physical activity among different subsets of patients with knee or hip osteoarthritis and the general population

   • Tim Pelle
   • Aniek A. O. M. Claassen
   • Cornelia H. M. van den Ende

   Observational Research Open access 07 January 2020 Pages: 383 - 392

   

6. All-cause hospitalizations and mortality in systemic lupus erythematosus in the US: results from a national inpatient database

   • Rashmi Dhital
   • Ramesh Kumar Pandey
   • Paras Karmacharya

   Comorbidities 26 November 2019 Pages: 393 - 397

7. Prevalence and clinical presentation of lymphoproliferative disorder in patients with primary Sjögren’s syndrome

   • Agata Sebastian
   • Marta Madej
   • Piotr Wiland

   Comorbidities Open access 01 February 2020 Pages: 399 - 404

8. Cardiovascular risk factors’ behavior during the early stages of the disease, in Hispanic rheumatoid arthritis patients: a cohort study

   • Irazú Contreras-Yáñez
   • Guillermo Guaracha-Basáñez
   • Virginia Pascual-Ramos

   Comorbidities 12 October 2019 Pages: 405 - 414

   

9. A prospective, longitudinal monocentric study on laser Doppler imaging of microcirculation: comparison with macrovascular pathophysiology and effect of adalimumab treatment in early rheumatoid arthritis

   • László Dávida
   • Vanda Pongrácz
   • György Kerekes

   Comorbidities Open access 19 December 2019 Pages: 415 - 424

   

10. Correction to: A prospective, longitudinal monocentric study on laser Doppler imaging of microcirculation: comparison with macrovascular pathophysiology and effect of adalimumab treatment in early rheumatoid arthritis

    • László Dávida
    • Vanda Pongrácz
    • György Kerekes

    Correction 06 January 2020 Pages: 425 - 426

    

11. Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis

    • Edit Végh
    • György Kerekes
    • Gabriella Szűcs

    Comorbidities Open access 17 December 2019 Pages: 427 - 436

    

12. Prevalence of high-sensitivity cardiac troponin T in real-life cohorts of psoriatic arthritis and general population: a cross-sectional study

    • Victoria Furer
    • Shani Shenhar-Tsarfaty
    • Ori Elkayam

    Comorbidities 23 October 2019 Pages: 437 - 444

13. Oral health and orofacial function in patients with rheumatoid arthritis

    • Susana Aideé González-Chávez
    • César Pacheco-Tena
    • Rosa María Campos-Torres

    Comorbidities 17 September 2019 Pages: 445 - 453

    

14. Periodontal disease and influence of periodontal treatment on disease activity in patients with rheumatoid arthritis and spondyloarthritis

    • Katarzyna Białowąs
    • Małgorzata Radwan-Oczko
    • Jerzy Świerkot

    Comorbidities Open access 07 November 2019 Pages: 455 - 463

    

15. The coexistence of gout in ankylosing spondylitis patients: a case control study

    • Tal Gonen
    • Shmuel Tiosano
    • Ora Shovman

    Comorbidities 19 October 2019 Pages: 465 - 470

    

16. Positive conversion of interferon-γ release assay in patients with rheumatic diseases treated with biologics

    • Hye Won Kim
    • Oh Chan Kwon
    • Min-Chan Park

    Comorbidities 09 January 2020 Pages: 471 - 479

    

17. Effect of TNF inhibitors on bone mineral density in rheumatoid arthritis patients receiving bisphosphonate: a retrospective cohort study

    • Jung Sun Lee
    • Doo-Ho Lim
    • Seokchan Hong

    Bone and Cartilage 14 August 2019 Pages: 481 - 487

18. Restrictive cardiomyopathy in a patient with systemic sclerosis and Fabry disease: a case-based review

    • Álvaro Arbeláez-Cortés
    • Diana C. Quintero-González
    • Jorge M. Rueda

    Case Based Review 10 October 2019 Pages: 489 - 497

    

19. Clonal relationship of marginal zone lymphoma and diffuse large B-cell lymphoma in Sjogren's syndrome patients: case series study and review of the literature

    • Vadim Romanovich Gorodetskiy
    • Natalya Alexandrovna Probatova
    • Andrey Borisovich Sudarikov

    Case Based Review Open access 09 November 2019 Pages: 499 - 506

    

20. Comment on “Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis”

    • Erkan Cure
    • Medine Cumhur Cure

    Correspondence 18 January 2020 Pages: 507 - 508

21. Reply to: Comment on “effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis” by Cure et al.

    • Zoltán Szekanecz

    Correspondence 30 January 2020 Pages: 509 - 509